Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michal Irony-Tur Sinai

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Genes, Chromosomes & Cancer|December 8, 2018
Genomic instability in fragile sites-still adding the piecesMichal Irony-Tur Sinai, Batsheva Kerem
Mutation Research|October 28, 2017
DNA replication stress drives fragile site instabilityMichal Irony-Tur Sinai, Batsheva Kerem
Emerging Topics in Life Sciences|October 25, 2023
Insights into common fragile site instability: DNA replication challenges at DNA repeat sequencesMichal Irony-Tur Sinai, Batsheva Kerem
International Immunopharmacology|July 28, 2009
IL2-caspase3 chimeric protein controls lymphocyte reactivity by targeted apoptosis, leading to amelioration of experimental autoimmune encephalomyelitisMichal Irony-Tur-Sinai, Michal Lichtenstein, Talma Brenner, et al.
Journal of Neuroimmunology|August 8, 2008
Acetylcholinesterase inhibitors and cholinergic modulation in Myasthenia Gravis and neuroinflammationTalma Brenner, Eran Nizri, Michal Irony-Tur-Sinai, et al.
Journal of the Neurological Sciences|January 28, 2009
Immunomodulation of EAE by alpha-fetoprotein involves elevation of immune cell apoptosis markers and the transcription factor FoxP3Michal Irony-Tur-Sinai, Nikolaos Grigoriadis, Dimitrios Tsiantoulas, et al.
Pharmacology|December 2, 2006
Novel approaches to treatment of autoimmune neuroinflammation and lessons for drug developmentEran Nizri, Michal Irony-Tur-Sinai, Nikolaos Grigoriadis, et al.
International Immunopharmacology|July 17, 2007
IBU-octyl-cytisine, a novel bifunctional compound eliciting anti-inflammatory and cholinergic activity, ameliorates CNS inflammation by inhibition of T-cell activityEran Nizri, Michal Irony-Tur-Sinai, Iris Lavon, et al.
Experimental Neurology|January 21, 2006
Amelioration of autoimmune neuroinflammation by recombinant human alpha-fetoproteinMichal Irony-Tur-Sinai, Nikolaos Grigoriadis, Athanasios Lourbopoulos, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 23, 2009
Activation of the cholinergic anti-inflammatory system by nicotine attenuates neuroinflammation via suppression of Th1 and Th17 responsesEran Nizri, Michal Irony-Tur-Sinai, Omer Lory, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Genes, Chromosomes & Cancer|December 8, 2018
Genomic instability in fragile sites-still adding the piecesMichal Irony-Tur Sinai, Batsheva Kerem
Mutation Research|October 28, 2017
DNA replication stress drives fragile site instabilityMichal Irony-Tur Sinai, Batsheva Kerem
Emerging Topics in Life Sciences|October 25, 2023
Insights into common fragile site instability: DNA replication challenges at DNA repeat sequencesMichal Irony-Tur Sinai, Batsheva Kerem
International Immunopharmacology|July 28, 2009
IL2-caspase3 chimeric protein controls lymphocyte reactivity by targeted apoptosis, leading to amelioration of experimental autoimmune encephalomyelitisMichal Irony-Tur-Sinai, Michal Lichtenstein, Talma Brenner, et al.
Journal of Neuroimmunology|August 8, 2008
Acetylcholinesterase inhibitors and cholinergic modulation in Myasthenia Gravis and neuroinflammationTalma Brenner, Eran Nizri, Michal Irony-Tur-Sinai, et al.
Journal of the Neurological Sciences|January 28, 2009
Immunomodulation of EAE by alpha-fetoprotein involves elevation of immune cell apoptosis markers and the transcription factor FoxP3Michal Irony-Tur-Sinai, Nikolaos Grigoriadis, Dimitrios Tsiantoulas, et al.
Pharmacology|December 2, 2006
Novel approaches to treatment of autoimmune neuroinflammation and lessons for drug developmentEran Nizri, Michal Irony-Tur-Sinai, Nikolaos Grigoriadis, et al.
International Immunopharmacology|July 17, 2007
IBU-octyl-cytisine, a novel bifunctional compound eliciting anti-inflammatory and cholinergic activity, ameliorates CNS inflammation by inhibition of T-cell activityEran Nizri, Michal Irony-Tur-Sinai, Iris Lavon, et al.
Experimental Neurology|January 21, 2006
Amelioration of autoimmune neuroinflammation by recombinant human alpha-fetoproteinMichal Irony-Tur-Sinai, Nikolaos Grigoriadis, Athanasios Lourbopoulos, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 23, 2009
Activation of the cholinergic anti-inflammatory system by nicotine attenuates neuroinflammation via suppression of Th1 and Th17 responsesEran Nizri, Michal Irony-Tur-Sinai, Omer Lory, et al.
Pageof 2